InvestorsHub Logo
Followers 829
Posts 119621
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 739

Monday, 02/21/2022 12:47:18 PM

Monday, February 21, 2022 12:47:18 PM

Post# of 803
ABT fell 6% cumulatively_on_Thu/Fri_due_to infant-formula recall:

https://finance.yahoo.com/news/abbott-voluntarily-recalls-powder-formulas-221100997.html

Although ABT’s PR was issued after the market close on Thursday, news of the recall was already on the internet during trading hours.

Although ABT says the effect of the recall will not be material to 1Q21 financial results and ABT has reiterated 2022 non-GAAP EPS guidance of $4.70+, the blow to ABT’s reputation as a quality vendor may linger. Still, the 6% hit to the share price Thursday and Friday, which erased $13B in enterprise value, probably exceeded the actual damage on an NPV basis.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News